Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer

A Southeastern Cancer Study Group trial

S. D. Williams, R. Birch, Lawrence Einhorn

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Twenty-two evaluable patients with all cell types of advanced thyroid cancer were treated with the combination of doxorubicin (60 mg/m2) plus cisplatin (60 mg/m2). There were two brief partial remissions (9.1%). There was considerable toxicity, with one drug-related death. Combination chemotherapy as given in this study was not effective for this patient population.

Original languageEnglish
Pages (from-to)405-407
Number of pages3
JournalCancer Treatment Reports
Volume70
Issue number3
StatePublished - 1986

Fingerprint

Thyroid Neoplasms
Doxorubicin
Cisplatin
Combination Drug Therapy
Neoplasms
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer : A Southeastern Cancer Study Group trial. / Williams, S. D.; Birch, R.; Einhorn, Lawrence.

In: Cancer Treatment Reports, Vol. 70, No. 3, 1986, p. 405-407.

Research output: Contribution to journalArticle

@article{de4fa817e3764b32a1fb98989f5882a2,
title = "Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: A Southeastern Cancer Study Group trial",
abstract = "Twenty-two evaluable patients with all cell types of advanced thyroid cancer were treated with the combination of doxorubicin (60 mg/m2) plus cisplatin (60 mg/m2). There were two brief partial remissions (9.1{\%}). There was considerable toxicity, with one drug-related death. Combination chemotherapy as given in this study was not effective for this patient population.",
author = "Williams, {S. D.} and R. Birch and Lawrence Einhorn",
year = "1986",
language = "English",
volume = "70",
pages = "405--407",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer

T2 - A Southeastern Cancer Study Group trial

AU - Williams, S. D.

AU - Birch, R.

AU - Einhorn, Lawrence

PY - 1986

Y1 - 1986

N2 - Twenty-two evaluable patients with all cell types of advanced thyroid cancer were treated with the combination of doxorubicin (60 mg/m2) plus cisplatin (60 mg/m2). There were two brief partial remissions (9.1%). There was considerable toxicity, with one drug-related death. Combination chemotherapy as given in this study was not effective for this patient population.

AB - Twenty-two evaluable patients with all cell types of advanced thyroid cancer were treated with the combination of doxorubicin (60 mg/m2) plus cisplatin (60 mg/m2). There were two brief partial remissions (9.1%). There was considerable toxicity, with one drug-related death. Combination chemotherapy as given in this study was not effective for this patient population.

UR - http://www.scopus.com/inward/record.url?scp=0022588769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022588769&partnerID=8YFLogxK

M3 - Article

VL - 70

SP - 405

EP - 407

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 3

ER -